retatrutide cause cancer Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the Demand for Unapproved Weight-Loss Drug

They lose lean muscle mass and regain the weight, risking conditions like sarcopenic obesity, leaving them potentially worse off than before they started the medication

Injectable forms can still deliver better long-term weight management results than oral ones, especially in the non-diabetic population

Some may experience mild digestive discomfort at higher doses

Examples: chicken turkey, and extra lean beef

Managing these effects successfully requires understanding the complete GLP-1 medications treatment process, including when to adjust doses, what symptoms require medical attention, and how to optimize nutrition during the adjustment period

These recommendations, when combined with the medications effects, can help individuals optimize their weight loss journey and achieve long-term success